Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
Clinical trial NCT06418087 · RECRUITING
Trial details
- NCT number
- NCT06418087
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2026-12-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.